News - Pfizer

Filter

Current filters:

Pfizer

Popular Filters

76 to 100 of 403 results

Negative NICE news for Pfizer leukemia drug

16-07-2013

There was disappointment for global drugs behemoth Pfizer (NYSE: OFE) when the UK drugs watchdog the…

BosulifEuropeOncologyPfizerPharmaceuticalPricingRegulation

Pfizer gets Swiss nod for Xeljanz for rheumatoid arthritis

16-07-2013

US drug giant Pfizer (NYSE: PFE) said its rheumatoid arthritis (RA) therapy Xeljanz (tofacitinib) has…

Anti-Arthritics/RheumaticsEuropePfizerPharmaceuticalRegulationTakeda NycomedXeljanz

US FDA accepts Bristol-Myers/Pfizer' Eliquis sNDA

12-07-2013

US pharma major Bristol-Myers Squibb (NYSE: BMY) and behemoth Pfizer (NYSE: PFE) announced that the US…

Bristol-Myers SquibbCardio-vascularEliquisNorth AmericaPfizerPharmaceuticalRegulation

Pfizer gets EU approval for Prevenar 13 for adults aged 18-49

10-07-2013

US drug giant Pfizer (NYSE: PFE) has today received European approval for an expanded indication of its…

EuropePfizerPharmaceuticalPrevenarRegulationVaccines

New EULAR recommendations address use of synthetic and biological DMARDs

05-07-2013

The European League Against Rheumatism (EULAR) has this week released updated recommendations for the…

ActemraBiotechnologyBristol-Myers SquibbEuropeHealthcareMabTheraOrenciaPfizerPharmaceuticalRegulationRocheXeljanz

Impax Labs confirms patent challenge to Pfizer/UCB's Toviaz

04-07-2013

US specialty drugmaker Impax Laboratories (Nasdaq: IPXL) yesterday confirmed that it has initiated a…

Gastro-intestinalsGenericsImpax LaboratoriesNorth AmericaPatentsPfizerToviazUCB

Bioventus in-licenses exclusive rights to Pfizer's BMP portfolio

02-07-2013

USA-based orthopedic healing specialist Bioventus, a spin out from the UK's Smith & Nephew to an Essex…

Anti-Arthritics/RheumaticsBioventusGlobalhyaluronic acidLicensingPfizerPharmaceutical

Onyx Pharma rejects Amgen's unsolicited $120 per share takeover offer

01-07-2013

Following a day of speculation and rumor on Friday, US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX)…

AmgenBayerBiotechnologyCelgeneMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizerRoche

Pfizer, GSK and Siemens join R&D consortium with A*STAR' on pharma production

20-06-2013

US and UK pharma giants Pfizer (NYSE: PFE) and GlaxoSmithKline's (LSE: GSK) units Pfizer Asia Pacific…

Asia-PacificGlaxoSmithKlinePfizerPharmaceuticalProductionResearch

Protalix BioTherapeutics enters Gaucher drug Uplyso deal with Brazil's Ministry of Health

19-06-2013

Israel-based Protalix BioTherapeutics (TASE:PLX) has entered into a supply and technology transfer agreement…

FiocruzMarkets & MarketingPfizerPharmaceuticalProtalix BioTherapeuticsRare diseasesSouth AmericaUplyso

Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors

17-06-2013

Bazedoxifene, a drug approved in some countries to treat osteoporosis, has now been shown to stop the…

Anti-Arthritics/RheumaticsbazedoxifeneOncologyPfizerPharmaceuticalResearch

Abcam in deal with Pfizer to supply compounds to researchers

12-06-2013

UK-based Abcam (AIM: ABC), a producer and distributor of protein research tools, has entered into a license…

AbcamCardio-vascularLicensingNeurologicalOncologyPfizerPharmaceuticalResearch

CytomX signs up to $635 million oncology deal with Pfizer

07-06-2013

US biotech firm CytomX Therapeutics, which is developing a new generation of targeted antibody therapeutics,…

BiotechnologyCytomX TherapeuticsLicensingOncologyPfizerPharmaceuticalResearch

Indian IPAB provides relief for Pfizer in Sutent patent revocation case

05-06-2013

India's Intellectual Property Appellate Board (IPAB) has provided global pharma behemoth Pfizer (NYSE:…

Asia-PacificCiplaPatentsPfizerPharmaceuticalSutent

Pfizer to split-off remaining 80% interest in Zoetis

22-05-2013

Zoetis Inc (Nasdaq: ZTS), the animal health business of which US pharma behemoth Pfizer (NYSE: PFE) spun…

FinancialMergers & AcquisitionsPfizerPharmaceuticalZoetis

76 to 100 of 403 results

Back to top